Omalizumab Monoclonal Antibody from Japan
Omalizumab is a recombinant humanized monoclonal antibody that binds IgE and is used to treat severe asthma. Imported as an unmixed bulk product without retail packaging, it falls under tariff item 3002.13.00 as an immunological product.
Duty Rate — Japan → Canada
0%
Import Tips
• Confirm the product is not dissolved in water or any other solvent to retain the unmixed classification
• Provide a certificate of analysis to CBSA demonstrating the product's purity
• Verify if a Canadian importer's licence is needed under the Food and Drug Regulations